Mucin prevents the breakdown of pneumonia-causing bacteria

Mucin inhibits pneumococcal stationary phase autolysis

NIH-funded research St. Jude Children's Research Hospital · NIH-10997930

This study looks at how a substance in mucus called mucin helps the harmful bacteria that cause infections like bronchitis and pneumonia in kids survive longer, with the goal of finding new ways to fight these infections in young patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital NIH-funded
Lab location1 site (Memphis, United States)
Project IDNIH-10997930 on NIH RePORTER

What this research studies

This research investigates how mucin, a component of mucus, affects the survival of Streptococcus pneumoniae, a bacterium responsible for serious infections like bronchitis and pneumonia in children. The study focuses on how mucin inhibits the autolysis, or self-destruction, of these bacteria, allowing them to survive longer in the body. By understanding this process, researchers aim to uncover new ways to combat bacterial infections, particularly in young patients who are more vulnerable. The methodology involves laboratory experiments that assess bacterial behavior in the presence of mucin compared to traditional growth media.

Who could benefit from this research

Good fit: Ideal candidates for this research are children aged 0-11 years who are at risk for or suffering from respiratory infections caused by Streptococcus pneumoniae.

Not a fit: Patients who are adults or those with infections caused by other types of bacteria may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance the effectiveness of antibiotics against pneumonia-causing bacteria in children.

How similar studies have performed: Other research has shown promising results in understanding bacterial survival mechanisms, making this approach a potentially valuable advancement in treating bacterial infections.

Where this research is happening

Memphis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.